Range Low Price High Price Comment
30 days $0.470 $0.470 Thursday, 17th Aug 2023 CYAD stock ended at $0.470. During the day the stock fluctuated 0% from a day low at $0.470 to a day high of $0.470.
90 days $0.470 $0.470
52 weeks $0.460 $3.07

Historical Celyad SA prices

Date Open High Low Close Volume
2022-09-23 $1.71 $1.71 $1.62 $1.64 11 549
2022-09-22 $1.72 $1.86 $1.56 $1.75 5 634
2022-09-21 $1.82 $1.82 $1.71 $1.80 3 476
2022-09-20 $1.84 $1.90 $1.71 $1.72 10 370
2022-09-19 $1.84 $1.88 $1.75 $1.76 4 305
2022-09-16 $1.85 $1.87 $1.79 $1.80 15 882
2022-09-15 $1.88 $1.88 $1.85 $1.85 966
2022-09-14 $1.90 $1.90 $1.88 $1.88 1 153
2022-09-13 $1.87 $1.87 $1.86 $1.86 2 690
2022-09-12 $1.88 $1.88 $1.79 $1.79 1 884
2022-09-09 $1.86 $1.95 $1.84 $1.84 9 089
2022-09-08 $1.90 $1.91 $1.79 $1.79 6 790
2022-09-07 $1.89 $1.91 $1.80 $1.84 1 758
2022-09-06 $1.88 $1.93 $1.82 $1.82 3 998
2022-09-02 $1.90 $1.93 $1.90 $1.90 6 378
2022-09-01 $1.90 $1.90 $1.79 $1.79 8 115
2022-08-31 $1.94 $1.99 $1.94 $1.96 7 181
2022-08-30 $1.94 $1.94 $1.91 $1.93 6 224
2022-08-29 $1.96 $1.97 $1.90 $1.94 7 066
2022-08-26 $1.94 $2.02 $1.91 $1.99 21 826
2022-08-25 $1.98 $1.99 $1.90 $1.95 10 138
2022-08-24 $1.98 $2.06 $1.98 $2.00 3 966
2022-08-23 $2.00 $2.05 $2.00 $2.04 1 314
2022-08-22 $1.95 $2.05 $1.95 $1.97 11 832
2022-08-19 $2.04 $2.05 $1.86 $1.91 14 497
Click to get the best stock tips daily for free!

About Celyad SA

Celyad SA Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT